English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Strategies for Developing Cancer Theranostics Approaches Other
2024-01-01
Authors:  Wang, Zikang;  Wang, Wanhe;  Leung, Chung Hang
Favorite | TC[WOS]:1 TC[Scopus]:1 | Submit date：2024/05/16
Magnetic Nanoparticles  Diagnosis  Probes  Chemotherapy  Biomarkers  Complexes  Future  
Pharmacogenomic profiling of pediatric acute myeloid leukemia to identify therapeutic vulnerabilities and inform functional precision medicine Journal article
Wang Han, Chan Kathy Yuen Yee, Cheng Chi Keung, Ng Margaret HL, Lee Po Yi, Cheng Frankie Wai Tsoi, Lam Grace Kee See, Chow Tin Wai, Ha Shau Yin, Chiang Alan KS, Leung Wing Hang, Leung Anskar YH, Wang Chi Chiu, Zhang Tao, Zhang Xiao-Bing, So Chi Chiu, Yeun Yuet Ping, Sun Qiwei, Zhang Chi, Xu Yaqun, Cheung John Tak Kit, Ng Wing Hei, Patrick Tang Ming-Kuen, Kang Wei, To Ka-Fai, Lee Wayne Yuk Wai, Wong Raymond SM, Poon Ellen Ngar Yun, Zhao Qi, Huang Junbin, Chen Chun, Yeun Patrick Man Pan, Li Chi-kong, Leung Alex Wing Kwan, Leung Kam Tong. Pharmacogenomic profiling of pediatric acute myeloid leukemia to identify therapeutic vulnerabilities and inform functional precision medicine[J]. Blood Cancer Discovery, 2022, 3(6), 516-535.
Authors:  Wang Han;  Chan Kathy Yuen Yee;  Cheng Chi Keung;  Ng Margaret HL;  Lee Po Yi; et al.
Favorite | TC[WOS]:8 TC[Scopus]:8 | Submit date：2023/08/28
High-throughput strategy accelerates the progress of marine anticancer peptide drug development Journal article
Peng Lyu, Hang F. Kwok. High-throughput strategy accelerates the progress of marine anticancer peptide drug development[J]. Recent Patents on Anti-Cancer Drug Discovery, 2019, 14(1), 2-4.
Authors:  Peng Lyu;  Hang F. Kwok
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:2.5/2.6 | Submit date：2022/05/23
High-throughput Strategy Accelerates the Progress of Marine Anticancer Journal article
Lyu, P., Kwok, H. F.. High-throughput Strategy Accelerates the Progress of Marine Anticancer[J]. Recent Patents on Anti-Cancer Drug Discovery, 2018, 1-3.
Authors:  Lyu, P.;  Kwok, H. F.
Favorite |  | Submit date：2022/06/02
Marine-derived peptide  Drug development  Anticancer  
APC/C dysfunction limits excessive cancer chromosomal instability Journal article
Sansregret L, Patterson JO, Dewhurst S, López-García C, Koch A, McGranahan N, Chao WCH, Barry DJ, Rowan A, Instrell R, Horswell S, Way M, Howell M, Singleton MR, Medema RH, Nurse P, Petronczki M, Swanton C. APC/C dysfunction limits excessive cancer chromosomal instability[J]. Cancer Discovery, 2017, 7(2).
Authors:  Sansregret L;  Patterson JO;  Dewhurst S;  López-García C;  Koch A; et al.
Favorite | TC[WOS]:81 TC[Scopus]:81 | Submit date：2018/12/18
A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment Journal article
Platz E.A., Yegnasubramanian S., Liu J.O., Chong C.R., Shim J.S., Kenfield S.A., Stampfer M.J., Willett W.C., Giovannucci E., Nelson W.G.. A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment[J]. Cancer Discovery, 2011, 1(1), 68-77.
Authors:  Platz E.A.;  Yegnasubramanian S.;  Liu J.O.;  Chong C.R.;  Shim J.S.; et al.
Favorite | TC[WOS]:136 TC[Scopus]:153 | Submit date：2019/01/15